Planned Asia-Pacific trial of NBTXR 3 intratumoral implant (activated by radiotherapy) for the treatment of cancer
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2015
At a glance
- Drugs NBTXR 3 (Primary)
- Indications Head and neck cancer; Liver cancer; Oesophageal cancer; Oropharyngeal cancer; Rectal cancer; Solid tumours
- Focus Therapeutic Use
- 12 Jun 2015 Status changed from recruiting to planning.
- 12 Jun 2015 Status changed from planning to recruiting.
- 29 Nov 2012 New trial record